TRENDS
Bivalent COVID-19 vaccines offer incremental benefits in elderly: Kang
According to government officials, an Indian bivalent vaccine – which uses two variations of the coronavirus strain – is already in the pipeline.
TRENDS
India sees rise in Covid variants driving cases abroad, govt steps up surveillance
The detection rate of BA.5 variant, whose sub-strain BF.7 is wreaking havoc in China, went up from 26% in September to 38% in December, while that of BQ.1.1 rose to 33% in December from 27% in September. Official says the rise is marginal
TRENDS
COVID policy-making task force hasn’t met since April
The National Task Force on COVID has met only seven times this year and some of its 24 members have retired
TRENDS
INSACOG closely assessing situation, vigilant on COVID mutant: NK Arora
The co-chair of Indiá’s coronavirus genomic surveillance programme says a coordinated assessment has helped India detect several variants and contain outbreaks in the past
TRENDS
Zydus, Baba Ramdev firm among 16 barred from selling drugs in Nepal
Nepal’s drug department said only a few of the Indian companies were registered and most were new and still awaiting approval to sell drugs.
TRENDS
Dr Reddy’s completes phase 1 study of key anti-rheumatic biosimilar drug
The company is now initiating a global study to compare the efficacy, safety and immunogenicity of the proposed medication.
TRENDS
WHO says Swiss lab confirmed cough syrup contamination, but is silent on proof of causality
The WHO maintains that its labs have confirmed dangerous levels of ethylene glycol and diethylene glycol, which should not be present in any medicine ever.
TRENDS
Biological E gets DCGI nod to market Pneumococcal Conjugate Vaccine in India
The company said 14-valent paediatric Pneumococcal Conjugate Vaccine (PCV14) against S. pneumoniae infection may be administered to infants 6, 10 and 14 weeks of age in three doses.
TRENDS
FDA's warning letter points to cGMP violations at Halol facility: Sun Pharma
The US FDA last week listed the Halol facility in Gujarat under import alert with products manufactured at the unit now subject to refusal of admission in the US market.
TRENDS
Dr Reddy’s subsidiary Aurigene Oncology stops clinical trial for psoriasis drug in US
After phase 2 results, the company's CEO said the drug will not add desirable benefit to patients with moderate to severe, psoriasis, hence, the firm decided to stop the clinical development of AUR101 as an oral drug in psoriasis.
INDIA
Gambian children’s death: Maiden Pharma’s cough syrups of standard quality, no contaminants found, says govt
Maiden Pharmaceuticals welcomed the government test lab reports and said that the drugs produced by the company weren’t adulterated.
INDIA
Takeda expands rare disease portfolio in India, plans foray in oncology segment
Japan based pharma company which recently got marketing authorization for its dengue vaccine in European Union, said the firm is progressing with regulatory filings for the vaccine candidate in endemic and non-endemic countries around the world.
INDIA
Chinese firms behind AIIMS Delhi server attack: Govt sources
Of the 100 servers, five physical ones were successfully infiltrated by the hackers
TRENDS
Moderna, Merk’s mRNA cancer vaccine shows promising result in trials
Moderna and Merck plan to discuss results with regulatory authorities and initiate a Phase 3 study in melanoma in 2023 and rapidly expand to additional tumor types.
INDIA
Increase taxes on tobacco products, disincentivize consumption: Parliamentary panel to govt
The Committee has recommended the government to abolish designated smoking areas in airports, hotels, and restaurants and encourage a smoke free policy in organisations.
TRENDS
Committed to maintain highest quality, FDA warning letter on Bardez plant won’t impact supplies: Glenmark
The pharma company says it is committed to work with the US FDA to implement necessary corrective measures in the manufacturing facility in Goa.
INDIA
Have firm plans to bring in drugs from global pipeline to tackle India’s NCD challenges: Gagandeep Singh Bedi, AstraZeneca India
Complementing the government for coming out with the rare disease policy, the AstraZeneca India's MD said he expects to work very closely with the government, funding groups, patients and the industry to make sure patients are able to easily access drugs for rare disease.
TRENDS
Small retailers, wholesalers are up in arms against pricing, discounts of online pharmacies: Here's why
They allege that the practice of selling medicines online is wrong, as these online pharmacies threaten the very existence of retailers. Also, they say, the online pharmacies are selling medicines at less than production price.
TRENDS
Stop YouTube learnings: Dental Council’s guidelines to maxillofacial surgeons for cosmetic procedures
As per the apex dental body, the aesthetic procedures can be performed by Oral and Maxillofacial surgeons after adequate training as per the curriculum.
TRENDS
Viatris acquisition allows us to offer a full solution to healthcare systems globally: Biocon Biologics CEO
Biosimilars are clearly the answer to some of the challenges before global healthcare agencies, says Shreehas Tambe.
TRENDS
After AIIMS, hackers attack ICMR website 6,000 times in a day
The attack on India's premier medical research institute's website comes at a time when AIIMS servers have been down for two weeks due to a ransomware attack.
BUSINESS
JB Pharma slashes price of critical heart failure medicine in India
The company has slashed the price of Azmarda (Saccubutril-Valsartan), 50 mg, to Rs 39.6 per tablet as against Rs 78 per tablet earlier
TRENDS
Drug regulator stalls approval for sale of Biological E’s pneumococcal vaccine
Two batches of the vaccine candidate are said to have failed testing parameters
BUSINESS
AIIMS ransomware attack: Two system analysts suspended as officials scan 50 servers, 5K computers
Four servers for restoring e-hospital services have been scanned and are being prepared for databases and applications
